Legalize or not legalize drugs in Brazil?
DOI:
https://doi.org/10.25118/2763-9037.2014.v4.693Keywords:
legalization, drug abuse, public healthAbstract
The Global Commission on Drug Policies in 2011 announced that the “war on drugs has failed” and the legalization would be one of the answers to curb trafficking, violence, excessive incarceration and drug use among young people. However, it reinforces the strict necessity to consider the matter starting from a scientific perspective of what would be the hypothetical benefits that would result from drug´s legalization, primarily for public health. Thus, this article aims to briefly point out some of the key points based on evidence that reinforces that legalization in Brazil currently is an attitude at least hasty, careless and erroneous.
Downloads
Metrics
References
Relatório da Comissão Global de Políticas sobre Drogas, junho 2011. Disponível em URL: http://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Commission_Report_Portuguese.pdf. Acessado em 30/05/2013.
Laranjeira R. Legalização das Drogas e a Saúde Pública. Ciência e Saúde Coletiva. 2010; 15: 621-631.
Bessa MA. Contribuição à discussão sobre a legalização de drogas. Ciência e Saúde Coletiva, 2010, 15: 632-636.
Crippa JA, Hallak JE, Zuardi AW. Marijuana, feijoada and the debate on drug legalization.Front Psychiatry. 2013, 4:7.
Babín Vich F de A. The debate over drug legalization. Adicciones. 2013;25:6-9.
Svrakic DM, Lustman PJ, Mallya A, Lynn TA, Finney R, Svrakic NM. Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective. Mo Med. 2012;109:90-8.
MacCoun RJ. What can we learn from the Dutch cannabis coffeeshop system? Addiction. 2011 ;106:1899-910.
Gomes LF. Nova Lei de Tóxicos: descriminalização da posse de droga para consumo pessoal. Revistas Jurídicas,2006. Disponível em URL: http://www.mpba.mp.br/atuacao/criminal/material/nova_lei_toxicos_luiz_flavio_gomes.pdf. Acesso em 30/05/2013.
Mamber N. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society. Cornell J Law Public Policy. 2006 Summer; 15:619-64.
Amirav I, Luder A, Viner Y, Finkel M. Decriminalization of cannabis--potential risks for children?Acta Paediatr. 2011;100:618-9.
Bostwick JM. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc. 2012 ;87:172-86.
Bretteville Jensen AL e Williams J. Decriminalization and Initiation into Cannabis Use. Department of Economics. Working Paper Series. 2011, 3: 1-34
URL: http://www.idt.pt/PT/Estatistica/Documents/2012/REDUCAO_PROCURA_CONSUMOS/2_RA_2011_TRATAMENTO.pdf. Acesso em 30.05.2013.
Afeganistão se torna país com maior proporção de viciados em drogas. URL: http://g1.globo.com/mundo/noticia/2013/04/afeganistao-se-torna-pais-com-maiorproporcao-de-viciados-em-drogas.html. Acesso em 13/04/2013.
Diehl A, Cordeiro DC, Laranjeira R. Dependência Química: prevenção, tratamento e políticas públicas. Editora Artmed, Porto Alegre, 2011.
Caulkins JP, Kilmer B, MacCoun RJ, Pacula RL, Reuter P. Design considerations for legalizing cannabis: lessons inspired by analysis of California’s Proposition 19. Addiction. 2012 ;107:865-71.
Bretteville-Jensen AL. To legalize or not to legalize? Economic approaches to the decriminalization of drugs. Subst Use Misuse. 2006;41:555-65.
Reuter P. Can tobacco control endgame analysis learn anything from the US experience with illegal drugs? Tob Control. 2013;22:i49-i51.
Psychoyos D, Vinod KY. Marijuana, Spice ‘herbal high’, and early neural development: implications for rescheduling and legalization. Drug Test Anal. 2013 ;5: 27-45.
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2014 Alessandra Diehl, Hewdy Lobo Ribeiro
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
